Cargando…
The Implication of Low Dose Dimethyl Sulfoxide on Mitochondrial Function and Oxidative Damage in Cultured Cardiac and Cancer Cells
Although numerous studies have demonstrated the biological and multifaceted nature of dimethyl sulfoxide (DMSO) across different in vitro models, the direct effect of “non-toxic” low DMSO doses on cardiac and cancer cells has not been clearly explored. In the present study, H9c2 cardiomyoblasts and...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658933/ https://www.ncbi.nlm.nih.gov/pubmed/34885888 http://dx.doi.org/10.3390/molecules26237305 |
_version_ | 1784612845994901504 |
---|---|
author | Sangweni, Nonhlakanipho F. Dludla, Phiwayinkosi V. Chellan, Nireshni Mabasa, Lawrence Sharma, Jyoti R. Johnson, Rabia |
author_facet | Sangweni, Nonhlakanipho F. Dludla, Phiwayinkosi V. Chellan, Nireshni Mabasa, Lawrence Sharma, Jyoti R. Johnson, Rabia |
author_sort | Sangweni, Nonhlakanipho F. |
collection | PubMed |
description | Although numerous studies have demonstrated the biological and multifaceted nature of dimethyl sulfoxide (DMSO) across different in vitro models, the direct effect of “non-toxic” low DMSO doses on cardiac and cancer cells has not been clearly explored. In the present study, H9c2 cardiomyoblasts and MCF-7 breast cancer cells were treated with varying concentrations of DMSO (0.001–3.7%) for 6 days. Here, DMSO doses < 0.5% enhanced the cardiomyoblasts respiratory control ratio and cellular viability relative to the control cells. However, 3.7% DMSO exposure enhanced the rate of apoptosis, which was driven by mitochondrial dysfunction and oxidative stress in the cardiomyoblasts. Additionally, in the cancer cells, DMSO (≥0.009) led to a reduction in the cell’s maximal respiratory capacity and ATP-linked respiration and turnover. As a result, the reduced bioenergetics accelerated ROS production whilst increasing early and late apoptosis in these cells. Surprisingly, 0.001% DMSO exposure led to a significant increase in the cancer cells proliferative activity. The latter, therefore, suggests that the use of DMSO, as a solvent or therapeutic compound, should be applied with caution in the cancer cells. Paradoxically, in the cardiomyoblasts, the application of DMSO (≤0.5%) demonstrated no cytotoxic or overt therapeutic benefits. |
format | Online Article Text |
id | pubmed-8658933 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86589332021-12-10 The Implication of Low Dose Dimethyl Sulfoxide on Mitochondrial Function and Oxidative Damage in Cultured Cardiac and Cancer Cells Sangweni, Nonhlakanipho F. Dludla, Phiwayinkosi V. Chellan, Nireshni Mabasa, Lawrence Sharma, Jyoti R. Johnson, Rabia Molecules Article Although numerous studies have demonstrated the biological and multifaceted nature of dimethyl sulfoxide (DMSO) across different in vitro models, the direct effect of “non-toxic” low DMSO doses on cardiac and cancer cells has not been clearly explored. In the present study, H9c2 cardiomyoblasts and MCF-7 breast cancer cells were treated with varying concentrations of DMSO (0.001–3.7%) for 6 days. Here, DMSO doses < 0.5% enhanced the cardiomyoblasts respiratory control ratio and cellular viability relative to the control cells. However, 3.7% DMSO exposure enhanced the rate of apoptosis, which was driven by mitochondrial dysfunction and oxidative stress in the cardiomyoblasts. Additionally, in the cancer cells, DMSO (≥0.009) led to a reduction in the cell’s maximal respiratory capacity and ATP-linked respiration and turnover. As a result, the reduced bioenergetics accelerated ROS production whilst increasing early and late apoptosis in these cells. Surprisingly, 0.001% DMSO exposure led to a significant increase in the cancer cells proliferative activity. The latter, therefore, suggests that the use of DMSO, as a solvent or therapeutic compound, should be applied with caution in the cancer cells. Paradoxically, in the cardiomyoblasts, the application of DMSO (≤0.5%) demonstrated no cytotoxic or overt therapeutic benefits. MDPI 2021-12-01 /pmc/articles/PMC8658933/ /pubmed/34885888 http://dx.doi.org/10.3390/molecules26237305 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sangweni, Nonhlakanipho F. Dludla, Phiwayinkosi V. Chellan, Nireshni Mabasa, Lawrence Sharma, Jyoti R. Johnson, Rabia The Implication of Low Dose Dimethyl Sulfoxide on Mitochondrial Function and Oxidative Damage in Cultured Cardiac and Cancer Cells |
title | The Implication of Low Dose Dimethyl Sulfoxide on Mitochondrial Function and Oxidative Damage in Cultured Cardiac and Cancer Cells |
title_full | The Implication of Low Dose Dimethyl Sulfoxide on Mitochondrial Function and Oxidative Damage in Cultured Cardiac and Cancer Cells |
title_fullStr | The Implication of Low Dose Dimethyl Sulfoxide on Mitochondrial Function and Oxidative Damage in Cultured Cardiac and Cancer Cells |
title_full_unstemmed | The Implication of Low Dose Dimethyl Sulfoxide on Mitochondrial Function and Oxidative Damage in Cultured Cardiac and Cancer Cells |
title_short | The Implication of Low Dose Dimethyl Sulfoxide on Mitochondrial Function and Oxidative Damage in Cultured Cardiac and Cancer Cells |
title_sort | implication of low dose dimethyl sulfoxide on mitochondrial function and oxidative damage in cultured cardiac and cancer cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658933/ https://www.ncbi.nlm.nih.gov/pubmed/34885888 http://dx.doi.org/10.3390/molecules26237305 |
work_keys_str_mv | AT sangweninonhlakaniphof theimplicationoflowdosedimethylsulfoxideonmitochondrialfunctionandoxidativedamageinculturedcardiacandcancercells AT dludlaphiwayinkosiv theimplicationoflowdosedimethylsulfoxideonmitochondrialfunctionandoxidativedamageinculturedcardiacandcancercells AT chellannireshni theimplicationoflowdosedimethylsulfoxideonmitochondrialfunctionandoxidativedamageinculturedcardiacandcancercells AT mabasalawrence theimplicationoflowdosedimethylsulfoxideonmitochondrialfunctionandoxidativedamageinculturedcardiacandcancercells AT sharmajyotir theimplicationoflowdosedimethylsulfoxideonmitochondrialfunctionandoxidativedamageinculturedcardiacandcancercells AT johnsonrabia theimplicationoflowdosedimethylsulfoxideonmitochondrialfunctionandoxidativedamageinculturedcardiacandcancercells AT sangweninonhlakaniphof implicationoflowdosedimethylsulfoxideonmitochondrialfunctionandoxidativedamageinculturedcardiacandcancercells AT dludlaphiwayinkosiv implicationoflowdosedimethylsulfoxideonmitochondrialfunctionandoxidativedamageinculturedcardiacandcancercells AT chellannireshni implicationoflowdosedimethylsulfoxideonmitochondrialfunctionandoxidativedamageinculturedcardiacandcancercells AT mabasalawrence implicationoflowdosedimethylsulfoxideonmitochondrialfunctionandoxidativedamageinculturedcardiacandcancercells AT sharmajyotir implicationoflowdosedimethylsulfoxideonmitochondrialfunctionandoxidativedamageinculturedcardiacandcancercells AT johnsonrabia implicationoflowdosedimethylsulfoxideonmitochondrialfunctionandoxidativedamageinculturedcardiacandcancercells |